– from Partners Telemedicine talks with GEN’s Editor-in-Chief John Sterling about telemedicine applications in the biotechnology and pharmaceutical industries.

Previous articleDr. Hui Lu and Ann Reed
Next articleDOE to Invest $250 million to Develop BioFuels